Cancer Imaging | Home page

Time 2020-09-18 18:03:54

Web Name: Cancer Imaging | Home page

WebSite: http://cancerimagingjournal.biomedcentral.com

ID:51273

Keywords:

Imaging,Cancer,page,CancerImaging,Oncology,CancerResearch,Imaging/Radiology,Nucl

Description:

Immune-checkpoint inhibitors represent one of the most important therapy advancements in modern oncology. They are currently used for treatment of multiple malignant diseases especially at advanced, metastatic stages which were poorly therapeutically accessible in the past. A challenging aspect of these immunotherapies is that they may show atypical therapy response patterns such as pseudoprogression and demonstrate a different imaging spectrum of adverse reactions, both of which are crucial for radiologists to understand.In thisreview article,Thorsten Persigehl,Simon Lennartz Lawrence H. Schwartzprovideguidance for response assessment of oncologic patients under immunotherapy based on iRECIST criteria. Masterclass in Imaging of Gynaecological Cancer *2nd edition course.London, 16 October 2020.Masterclass in Imaging of Prostate Cancer *2nd edition course.London, 5 November 2020.ONLINE COURSE - Masterlcassin Imaging of Hepatobiliary Tumours.On the afternoons of 12 and 13 November, from 1pm (GMT).Further details and registration options are available viathe ICIS website. As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.We are trying our best to work through this crisis as efficiently and effectively as possible and thank you for your support and patience during these challenging times.Thumbnail image by Felipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license. We are pleased to announce a new cross-journal thematic series on 鈥樷€?strong>Artificial intelligence in Cancer imaging and diagnosis"to help bring together the latest research on the application of artificial intelligence in this field. Please click here for more information about this series.The thematic series is now open for submission of original research and review articles. Please click here to submit your manuscript to this series. Surprisingly, in contrast to the literature regarding the outcomes of imaging, the methods that underpin the generation of an imaging report and how to communicate the findings cogently to referring clinicians remain something of a 鈥榖lack box'. In thisthematic series, experts across various modalities detail their approach to reporting scans in particular disease settings.Please click here to visit the series collection page. Cancer Imaginginvites you to join our expert team of reviewers in assessing manuscripts. For consideration, please send a copy of your CV along with keywords and expertise to the Journal Editor. If you are a member of the International Cancer Imaging Society (ICIS), you can receive a 20% article processing charge (APC) discount for publishing in Cancer Imaging. Please email the Journal Editor for details. Cancer Imaging is an open access, peer-reviewed journal publishing original articles, reviews and editorials written by expert international radiologists working in oncology.The journal encompasses CT, MR, PET, ultrasound, radionuclide and multimodal imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.Please click here for more information. Prof Rodney Hicks,The Peter MacCallum Cancer Centre, AustraliaAssoc. Prof Annick Van den Abbeele,Dana-Farber Cancer Institute, USA Authors: Meijie Liu, Ning Mao, Heng Ma, Jianjun Dong, Kun Zhang, Kaili Che, Shaofeng Duan, Xuexi Zhang, Yinghong Shi and Haizhu Xie Content type: Research article 15 September 2020 Authors: Jia Guo, Zhaoqi Wang, Jianjun Qin, Hongkai Zhang, Wentao Liu, Yan Zhao, Yanan Lu, Xu Yan, Zhongxian Zhang, Ting Zhang, Shouning Zhang, Nickel Marcel Dominik, Ihab R. Kamel, Hailiang Li and Jinrong Qu Content type: Research article 10 September 2020 Authors: Shuai Liu, Lingfang Xia, Ziyi Yang, Huijuan Ge, Chunmei Wang, Herong Pan, Shaoli Song and Zhengrong Zhou Content type: Research article 10 September 2020 Authors: Yujie Li, Xiaolu Li, Xiaoduo Yu, Meng Lin, Han Ouyang, Lizhi Xie and Yuqing Shang Content type: Research article 28 August 2020 Authors: Taek Min Kim, Jeong Min Lee, Jeong Hee Yoon, Ijin Joo, Sae-Jin Park, Sun Kyung Jeon, Bernhard Schmidt and Sedlmair Martin Content type: Research article 18 August 2020 Authors: Martin Beeres, Marcus R枚mer, Boris Bodelle, Clara Lee, Tatjana Gruber-Rouh, Emmanuel Mbalisike, Josef M Kerl, Julian L Wichmann, Boris Schulz, Thomas J Vogl and Ralf W Bauer Content type: Research article 2 September 2014 We are delighted to announce that 鈥?a href="https://cancerimagingjournal.biomedcentral.com/articles/10.1186/s40644-018-0145-9" target="_blank" >Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival 鈥渆arly on鈥?in neoadjuvant treatment of breast cancer鈥?was the top cited articlepublished in Cancer Imagingof 2019.Congratulations to all of the authors involved with this research: Karen Drukker,Hui Li,Natalia Antropova,Alexandra Edwards,John Papaioannou andMaryellen L. Giger. A major focus of Prof Rodney Hicks' (Co-Editor-in-Chiefof Cancer Imaging)clinical research has been to assess the impact of PET on patient management and prognostic stratification. "A few years ago I changed the name of my department from Diagnostic Imaging to Cancer Imaging since it occurred to me that little of what we do is diagnostic. Increasingly, the role of imaging in cancer is in selecting, planning and monitoring treatment. The challenge of imaging science is to establish our techniques as prognostic and predictive biomarkers and to show that our results improve patient outcomes"Prof Rodney Hicks, Co-Editor-in-Chief,Cancer Imaging Speed77days to first decision for reviewed manuscripts only61 days to first decision for all manuscripts133days from submission to acceptance15 days from acceptance to publicationCitation Impact2.193 -2-year Impact Factor2.885 -5-year Impact Factor1.382-Source Normalized Impactper Paper (SNIP)0.939- SCImago Journal Rank (SJR)Usage360,800Downloads273 Altmetric Mentions

TAGS:Imaging Cancer page CancerImaging Oncology CancerResearch Imaging/Radiology Nucl

<<< Thank you for your visit >>>

Cancer Imaging is the only journal in Journal Citation Reports dedicated to solely publishing articles on the rapidly advancing area of imaging techniques in ...

Hot Websites